Volume 60, issue 11, November 2017
24 articles in this issue
-
-
-
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Authors (first, second and last of 12)
-
-
-
Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial
Authors (first, second and last of 12)
-
Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement
Authors (first, second and last of 9)
-
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
Authors (first, second and last of 11)
-
Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults
Authors (first, second and last of 6)
-
Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009
Authors (first, second and last of 4)
-
Screening for type 2 diabetes: do screen-detected cases fare better?
Authors (first, second and last of 7)
-
The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study
Authors (first, second and last of 4)
-
Perceived racism and incident diabetes in the Black Women’s Health Study
Authors (first, second and last of 6)
-
Immigration to Israel during childhood is associated with diabetes at adolescence: a study of 2.7 million adolescents
Authors (first, second and last of 8)
-
Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes
Authors (first, second and last of 5)
-
Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion
Authors (first, second and last of 18)
-
-
The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
Authors (first, second and last of 7)
-
VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells
Authors (first, second and last of 11)
-
FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes
Authors (first, second and last of 6)
-
Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes
Authors (first, second and last of 9)
-
Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor
Authors (first, second and last of 13)
-
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy
Authors (first, second and last of 4)
-
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy. Reply to Marathe CS, Rayner CK, Jones KL, et al [letter]
Authors (first, second and last of 9)
